FOXO3 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FOXO3 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>FOXO3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5X3</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>71 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>643 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus (cytoplasmic in inactive state)</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Forkhead box (Fox) family</td>
</tr>
<tr>
<td class="label">PDB Structure</td>
<td>2K8R, 2LCU, 4OG0</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>PI3K/Akt, MAPK/ERK, IKK</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent/Approach</td>
</tr>
<tr>
<td class="label">SIRT1 activators</td>
<td>Resveratrol, SRT2104</td>
</tr>
<tr>
<td class="label">Natural compounds</td>
<td>Curcumin, epigallocatechin gallate</td>
</tr>
<tr>
<td class="label">Phosphatase activators</td>
<td>[PP2A](/entities/pp2a) activators</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-FOXO3</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-fd52a7a0" style="color:#ce93d8" title="Score: 0.36">FOXO3-Longevity Pathway Epigenetic Repro...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">633 edges</a></td>
</tr>
</table>
Foxo3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
FOXO3 (Forkhead Box O3) is a transcription factor protein that regulates cellular stress response, longevity, DNA repair, and [apoptosis](/entities/apoptosis). It is a member of the O subclass of the forkhead box family of transcription factors, characterized by a conserved DNA-binding domain (forkhead domain). FOXO3 is evolutionarily conserved from C. elegans (daf-16) to humans and plays critical roles in cellular homeostasis, metabolic regulation, and organismal aging.
Structure
The FOXO3 protein contains several functional domains:
Forkhead DNA-binding domain (FDH): Residues 150-260, responsible for binding to FOX consensus sequences (5'-GTAAACAA-3')
Transactivation domain (TAD): C-terminal region containing multiple phosphorylation sites
Nuclear localization signal (NLS): Mediates nuclear import
Nuclear export signal (NES): Regulates cytoplasmic-nuclear shuttlingPost-translational modifications include phosphorylation (by Akt/PKB, SGK, ERK, JNK, IKK), acetylation (by p300/CBP), and ubiquitination (by MDM2, SKP2). These modifications determine FOXO3 subcellular localization and transcriptional activity. [@auto_35907249]
Normal Function
FOXO3 regulates a wide array of target genes involved in:
Stress Response
- Antioxidant genes: MnSOD (SOD2), catalase, GADD45
- DNA repair: GADD45, DDB2
- Protein quality control: [Autophagy](/entities/autophagy) genes (LC3, Beclin-1) [@auto_https:__doi.org_10.1080_15548627.2015.1100356]
Cell Cycle Regulation
- Cell cycle arrest: p21<sup>CIP1</sup> (CDKN1A), p27<sup>KIP1</sup> (CDKN1B)
- DNA synthesis inhibition: Replication initiators
Apoptosis
- Pro-apoptotic genes: BIM, PUMA (BBC3), FasL, TRAIL
- Anti-apoptotic regulation: Negative feedback on [NF-κB](/entities/nf-kb)
- Gluconeogenesis: PEPCK, G6Pase
- Lipid metabolism: Lipid droplet formation
- Mitochondrial function: PGC-1α regulation
Longevity and Aging
FOXO3 is one of the most robust longevity-associated genes in humans. Specific FOXO3 polymorphisms (SNPs) are associated with exceptional longevity across multiple populations. [@auto_32332845] FOXO3 mediates the effects of caloric restriction on lifespan extension.
Expression Pattern
FOXO3 is widely expressed in human tissues with highest expression in:
- Brain: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, substantia nigra
- Muscle: Skeletal muscle, cardiac muscle
- Endocrine tissues: Pancreas, adrenal gland
- Immune system: T cells, B cells, macrophages
In the brain, FOXO3 is expressed in [neurons](/entities/neurons) and glia, where it regulates stress response and autophagy. [@auto_37352918]
Role in Neurodegeneration
Alzheimer Disease
FOXO3 plays a complex neuroprotective role in AD:
- Oxidative stress response: FOXO3 activates antioxidant genes (MnSOD, catalase) to combat [Aβ](/proteins/amyloid-beta)-induced oxidative stress
- Aβ metabolism: FOXO3 influences [amyloid precursor protein](/entities/app-protein) (APP) processing and Aβ clearance
- [Tau](/proteins/tau) pathology: FOXO3 activation can reduce [tau](/proteins/tau) phosphorylation through Akt pathway modulation
- Autophagy induction: FOXO3 promotes clearance of toxic protein aggregates via autophagy [@auto_https:__doi.org_10.1080_15548627.2015.1100356]
- Synaptic plasticity: FOXO3 regulates genes important for synaptic function and memory
Therapeutic strategies targeting FOXO3 in AD include:
- SIRT1 activators (resveratrol) that deacetylate and activate FOXO3
- Natural compounds that promote FOXO3 nuclear translocation
- Gene therapy approaches to increase FOXO3 expression
Parkinson Disease
FOXO3 provides neuroprotection in PD models:
- Dopaminergic neuron survival: FOXO3 protects SNpc neurons from oxidative stress and mitochondrial dysfunction [@pmid40397062]
- [α-Synuclein](/proteins/alpha-synuclein) clearance: FOXO3-induced autophagy can clear α-synuclein aggregates [@auto_https:__doi.org_10.1080_15548627.2015.1100356]
- Mitochondrial quality control: FOXO3 regulates mitophagy genes (PINK1, Parkin-independent pathways)
- Inflammation modulation: FOXO3 restrains neuroinflammatory responses [@auto_37352918]
Amyotrophic Lateral Sclerosis
FOXO3 may play protective or pathogenic roles depending on context:
- Motor neuron survival under oxidative stress
- Regulation of autophagy in SOD1 mutant models
- Potential therapeutic target for ALS [@auto_40374649]
Huntington Disease
- FOXO3 activation may protect against mutant [huntingtin](/proteins/huntingtin-protein) (mHTT) toxicity
- Could promote clearance of mHTT aggregates via autophagy [@auto_https:__doi.org_10.1080_15548627.2015.1100356]
Therapeutic Implications
Research in vascular cells engineered to overexpress FOXO3 demonstrates promising protective and regenerative effects on blood vessels [@auto_30661960].
Research Directions
- Developing brain-penetrant FOXO3 activators
- Understanding FOXO3 isoform-specific functions
- Biomarker development for FOXO3 activity
- Combination therapies with autophagy inducers
Pathway & Interaction Diagram
Interactive diagram showing FOXO3 key relationships in the SciDEX knowledge graph (15 connections shown).
Mermaid diagram (expand to render)
See Also
- [FOXO3 Gene](/proteins/foxo3-protein)
- [FOXO1 Protein](/proteins/foxo1-protein)
- [SIRT1 Protein](/proteins/sirt1-protein)
- [PI3K/Akt Pathway](/mechanisms/pi3k-akt-pathway)
- [Autophagy Pathway](/mechanisms/autophagy-lysosomal-pathway)
- [Oxidative Stress Pathway](/mechanisms/oxidative-stress-pathway)
- [Alzheimer Disease](/diseases/alzheimers-disease)
- [Parkinson Disease](/diseases/parkinsons-disease)
External Links
- [UniProt: FOXO3](https://www.uniprot.org/uniprot/Q9Y5X3)
- [PDB: FOXO3](https://www.rcsb.org/structure/2K8R)
- [FOXO3 in the Brain](https://pubmed.ncbi.nlm.nih.gov/)
- [Human Longevity and FOXO3](https://longevity.science/)
Background
The study of Foxo3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@auto_37352918]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Lin L, et al. (2010). FOXO3 in neurodegeneration: Friend or foe? J Neurosci Res. PMID: 20862795(https://pubmed.ncbi.nlm.nih.gov/20862795/)
<sup>[2]</sup> Maiese K, et al. (2013). FoxO proteins: Critical regulators of oxidative stress and longevity. Adv Exp Med Biol. PMID: 23627656(https://pubmed.ncbi.nlm.nih.gov/23627656/)
<sup>[3]</sup> Kalinovich M, et al. (2020). FoxO transcription factors in aging and metabolic disease. J Mol Endocrinol. PMID: 32821042(https://pubmed.ncbi.nlm.nih.gov/32821042/)
<sup>[4]</sup> Kim MJ, et al. (2021). FOXO3 as a therapeutic target in neurodegenerative diseases. Front Cell Neurosci. PMID: 34262452(https://pubmed.ncbi.nlm.nih.gov/34262452/)
<sup>[5]</sup> Webb AE, Brunet A. (2014). FOXO transcription factors: Key regulators of cellular quality control. Biochim Biophys Acta. PMID: 24434149(https://pubmed.ncbi.nlm.nih.gov/24434149/)
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [FOXO3-Longevity Pathway Epigenetic Reprogramming](/hypothesis/h-fd52a7a0) — <span style="color:#ff8a65;font-weight:600">0.36</span> · Target: FOXO3